BONDANZA, ATTILIO
 Distribuzione geografica
Continente #
AS - Asia 3.580
NA - Nord America 1.879
EU - Europa 1.448
SA - Sud America 1.133
AF - Africa 79
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.130
Nazione #
US - Stati Uniti d'America 1.791
SG - Singapore 1.557
CN - Cina 930
BR - Brasile 928
SE - Svezia 579
HK - Hong Kong 476
VN - Vietnam 316
IT - Italia 272
RU - Federazione Russa 174
DE - Germania 122
AR - Argentina 90
IN - India 57
JP - Giappone 51
FI - Finlandia 47
GB - Regno Unito 47
AT - Austria 45
BD - Bangladesh 45
EC - Ecuador 43
CA - Canada 37
IE - Irlanda 34
FR - Francia 32
MX - Messico 32
ZA - Sudafrica 32
ID - Indonesia 26
IQ - Iraq 23
NL - Olanda 22
PY - Paraguay 21
CO - Colombia 19
PL - Polonia 19
MA - Marocco 15
IL - Israele 13
TR - Turchia 13
UA - Ucraina 13
UZ - Uzbekistan 11
PK - Pakistan 10
SA - Arabia Saudita 10
DZ - Algeria 9
CL - Cile 8
EG - Egitto 8
ES - Italia 8
UY - Uruguay 8
IR - Iran 7
PE - Perù 7
KE - Kenya 6
TN - Tunisia 6
VE - Venezuela 6
AU - Australia 5
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
KW - Kuwait 5
NZ - Nuova Zelanda 5
BA - Bosnia-Erzegovina 4
JM - Giamaica 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
CH - Svizzera 3
GR - Grecia 3
HU - Ungheria 3
KZ - Kazakistan 3
LV - Lettonia 3
PT - Portogallo 3
BO - Bolivia 2
DK - Danimarca 2
GT - Guatemala 2
JO - Giordania 2
LB - Libano 2
LT - Lituania 2
NP - Nepal 2
RS - Serbia 2
SY - Repubblica araba siriana 2
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
KH - Cambogia 1
MD - Moldavia 1
PH - Filippine 1
PR - Porto Rico 1
RO - Romania 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.130
Città #
Singapore 560
Hong Kong 471
Dallas 379
Shanghai 236
Ashburn 220
Hefei 193
Lawrence 185
Princeton 185
Beijing 119
Ho Chi Minh City 117
New York 101
Milan 89
São Paulo 69
Moscow 58
Hanoi 53
Los Angeles 44
Nuremberg 37
Rio de Janeiro 35
Dublin 33
Boardman 28
Helsinki 26
Munich 22
Belo Horizonte 20
Tokyo 20
Brasília 19
Guangzhou 19
Guayaquil 17
Seattle 17
Vienna 17
Johannesburg 16
Turku 16
Brooklyn 15
Quito 15
Warsaw 15
Curitiba 14
Washington 14
Biên Hòa 13
Da Nang 13
Phoenix 13
Campinas 12
Montreal 12
Porto Alegre 12
Boston 11
Chennai 11
Haiphong 11
The Dalles 11
Guarulhos 10
Shijiazhuang 10
Tashkent 10
Ankara 9
Can Tho 9
Denver 9
Mexico City 9
Orem 9
Salvador 9
San Jose 9
Toronto 9
Buenos Aires 8
Fortaleza 8
Hangzhou 8
Jiaxing 8
London 8
Naples 8
Poplar 8
Recife 8
Stockholm 8
Xi'an 8
Council Bluffs 7
Frankfurt am Main 7
Goiânia 7
Hải Dương 7
Montevideo 7
Reston 7
Santa Clara 7
Santo André 7
Zhengzhou 7
Asunción 6
Atlanta 6
Bauru 6
Campos dos Goytacazes 6
Caxias do Sul 6
Ciudad del Este 6
Montes Claros 6
Nairobi 6
Nova Iguaçu 6
Tianjin 6
Volta Redonda 6
Baghdad 5
Baku 5
Belém 5
Bergamo 5
Camaçari 5
Cape Town 5
Cascavel 5
Chapel Hill 5
Falls Church 5
Maceió 5
Marília 5
Monza 5
Natal 5
Totale 3.989
Nome #
Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients 191
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 164
Loss of mismatched HLA in leukemia after stem-cell transplantation 133
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 131
Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation 113
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 106
A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation 105
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 98
Anti-beta 2 glycoprotein I antibodies cause inflammation and recruit dendritic cells in platelet clearance 87
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party 84
A phase II multicenter trial of HSV-TK engineered donor lymphocytes after haplo-identical HSCT: Early immune reconstitution and abrogation of GvHD 82
Erratum: IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism (Molecular Therapy (2017) 25(10) (2254–2269), (S1525001617303143), (10.1016/j.ymthe.2017.06.029)) 82
A novel self-lipid antigen targets human T cells against CD1c(+) leukemias 79
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 77
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 75
A dual role for genetically modified lymphocytes in cancer immunotherapy 75
Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation 74
Leukemic blasts secondary to myelodysplastic syndromes are molecularly programmed to differentiate into functionally mature dendritic cells 74
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome 69
Anti-beta 2 glycoprotein I antibodies prevent the de-activation of platelets and sustain their phagocytic clearance 67
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 67
Graft-versus leukemia effect of HLA-haploidentical central-memory T cells expanded with leukemic APCs and modified with a suicide gene 66
Application of Donor Lymphocytes Expressing a Suicide Gene for Early GvL Induction and Later Control of GvH reactions after Bone Marrow Tranaplantation 65
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting 65
An apoptotic cell threshold for dendritic cell maturation and function. 65
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 64
Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis 62
CD4 CAR T Cells Drive Extensive CD8 CAR T Cell Expansion, Leading to Severe Cytokine Release Syndrome 61
Anti-phospholipid antibodies opsonize activated platelets for uptake by dendritic cells: relevance to epitope spreading in platelet autoimmunity. 59
Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation 58
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory 58
Apoptotic cell-pulsed dendritic cells break tolerance and accelerate lupus in NZB/W F1 mice. 57
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 55
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 54
B- and T-cell interactions in graft-versus-host disease 54
Erratum: Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory (Science Translational Medicine (2015) 7:319 (319er9)) 54
Autoantibody Production during Chronic Graft-Versus-Host Disease Does Not Associate with Long-Term Persistence of Host B Cells in Humans 53
Immunoediting of the genomic and transcriptional profile of acute myeloid leukaemia in response to allogeneic haematopoietic stem cell transplantation 52
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 52
Autologous haematopoietic stem cell transplantation in aggressive forms of neuromyelitis optica (NMO) and NMO spectrum disorders 51
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 51
From TCR Gene Transfer to TCR Gene Editing of Central Memory T Lymphocytes for Immunotherapy of Leukemia 49
T-N/SCM Pre-Selection Generates CAR T Cell Products Driving Superior Anti-Tumor Responses While Curtailing Severe CRS 48
SUICIDE GENE TRANSFER INTO DONOR LYMPHOCYTES ALLOWS EARLY AND EFFECTIVE IMMUNE-RECONSTITUTION AFTER FAMILY HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR LEUKEMIAS: RESULTS OF THE TK007 STUDY 48
In-vivo T-regs generation by rapamycin-mycophenolate-ATG as a new platform for GvHD prophylaxis in T-cell repleted unmanipulated haploidentical peripheral stem cell transplantation: results in 59 patients 47
Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality 47
IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism 47
CD44v6 is associated with chemoresistance induced by bone marrow-derived mesenchymal stromal cells 46
T Cell Suicide Gene Therapy Prompts Thymic Renewal in Adults After Haploidentical Hematopoietic Stem Cell Transplantation in the Absence of Post-Transplant Immunesuppression 46
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP 46
Rapid and effective immune reconstitution with HSV-TK engineered donor lymphocyte add-backs after Haplo-HSCT 45
Jon van Rood (1926-2017) 45
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 44
Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival 44
TNF-alpha coupled to membrane of apoptotic cells favors the cross-priming to melanoma antigens 43
Clinical pharmacology of CAR-T cells: linking cellular pharmacodynamics to pharmacokinetics and antitumor effects 43
Improving the safety of cell therapy with the TK-suicide gene. 43
Use of IL-7 and IL-15 for the genetic modification of memory T lymphocytes 43
Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation 43
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT 42
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation 41
Temporal, quantitative and functional characteristics of Single-KIR positive alloreactive NK cell recovery account for impaired graft versus leukemia activity after haploidentical HSCT 41
H1N1 vaccination post-allogeneic haematopoietic stem cell transplantation and the risk of GvHD 40
Naive-Derived Memory Stem T Cells: A Novel Promising Platform for Cancer Immune-Gene Therapy 40
Gene transfer of modified idiotype into dendritic cells for immunotherapy of non-Hodgkin lymphomas 40
Stability of human rapamycin-expanded CD4(+)CD25(+) T regulatory cells 40
CD4+ T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer 40
Overcoming the toxicity hurdles of genetically targeted T cells. 40
Editing human lymphocytes specificity for safe and effective adoptive immunoterapy of leukemia 40
Kinetics of acute and chronic GvHD control by ganciclovir in-vivo HSV-TK suicide gene activation: long-term GvHD-free survival in 57 patients after haploidentical TK-cells 40
Inflammation Converts Human Mesoangioblasts Into Targets of Alloreactive Immune Responses: Implications for Allogeneic Cell Therapy of DMD 39
Dual Transgenesis of T Cells with a CD44v6 CAR and a Suicide Gene for the Safe Eradication of Myeloid Leukemia and Myeloma 39
Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapies 39
Progress and prospects: graft-versus-host disease 38
T Cell Receptor Gene Transfer into Early Differentiated Lymphocytes by Lentiviral Vectors for Safe and Effective Adoptive Immune Therapy of Leukemia 38
TCR gene editing results in effective immunotherapy of leukaemia without the development of GvHD 38
Modulation of graft-versus-host disease induced by central memory suicide gene modified human T lymphocytes 37
TCR Gene Editing Results in Effective Immunotherapy of Leukemia without the Development of GvHD 37
Haploidentical HSCT: a 15-year experience at San Raffaele. 37
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells 37
Cytotoxicity Is Not Required for the Anti-Leukemia Efficacy of Human H-Y-Specitic CD4+T Lymphocytes In Vivo. 36
Dual Transgenesis of T Cells with a Novel CD44v6-Specific Chimeric Antigen Receptor and a Suicide Gene for Safe and Effective Targeting of Chemoresistance in Hematopoietic Tumors 36
Gene editing of naive and central memory T lymphocyte specificities for adoptive immune therapy of leukemia 36
Enforced IL-10 Expression Confers Type 1 Regulatory T Cell (Tr1) Phenotype and Function to Human CD4(+) T Cells 36
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 36
SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking. 36
Mother Donors Improve Outcomes after HLA Haploidentical Transplantation: A Study by the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation 36
Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses 35
Harnessing CD1-restricted T cells for the immunotherapy of leukemia 35
T Cell Receptor Gene Transfer into Naive and Central Memory Lymphocytes by Lentiviral Vectors for a Safe and Effective Adoptive Immune Therapy of Leukemia 35
T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation 35
uPA/uPAR system is active in immature dendritic cells derived from CD14(+)CD34(+) precursors and is down-regulated upon maturation 35
Editing human lumphocyte specificity for safe and effective adoptive immunotherapy 35
Use of common gamma-chain cytokines for the visualization, isolation and genetic modification of memory T lymphocytes 35
NON-CYTOLYTIC HY-SPECIFIC CD4+T CELLS MEDIATE A STRONG GRAFT-VERSUS-LEUKEMIA EFFECT VIA CXCR4 DOWN-REGULATION ON TARGET CELLS 35
Leukemic dendritic cells expand central-memory T lymphocytes from HCT donors able to react against the original leukemia in vitro and in vivo 35
Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens 35
IL-7 receptor expression identifies suicide gene-modified allospecific CD8(+) T cells capable of self-renewal and differentiation into antileukemia effectors 35
Molecular modification of idiotypes from B-cell lymphomas for expression in mature dendritic cells as a strategy to induce tumor-reactive CD4(+) and CD8(+) T-cell responses 34
HAPLO-SCT WITH TK plus LYMPHOCYTES PRODUCE LEUKEMIA FREE SURVIVAL COMPARABLE TO UNRELATED BONE MARROW AND CORD BLOOD TRANSPLANTATION IN HIGH RISK ACUTE LEUKEMIA: 'TK007' PHASE II STUDY FINAL ANALYSIS 34
Totale 5.534
Categoria #
all - tutte 70.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.378


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 1 1 0 5 0 0 0
2021/2022143 0 0 0 68 9 6 10 10 12 16 3 9
2022/20231.094 408 233 67 3 25 119 54 76 62 12 27 8
2023/2024567 26 22 49 52 50 114 59 51 8 30 22 84
2024/20252.647 306 30 34 113 71 186 309 218 477 373 258 272
2025/20263.687 582 626 718 1.231 511 19 0 0 0 0 0 0
Totale 8.215